The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- BioNTech and Lilly Partner on Cancer Immunotherapies (2015-05-11)
Eli Lilly and Company (NYSE:LLY) and BioNTech AG today announced they have entered into a research collaboration to discover novel cancer immunotherapies. The companies will seek to use the power of the body's own immune system to attack cancer cells and create pos...
- Juno Therapeutics Acquires Stage Cell Therapeutics GmbH (2015-05-11)
> Transaction Provides Transformative Cell Selection and Activation Capabilities, Advanced Manufacturing Automation, Improved Supply Chain, and Lower Expected Cost of Goods > Initial Payment of €52.5 Million in Cash (Approximately $59 Million) and 486,279 Shares...
- MorphoSys Acquires Lanthio Pharma for €20m (2015-05-07)
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that it has acquired all outstanding shares of the Dutch biopharmaceutical company Lanthio Pharma B.V. The transaction brings Lanthio Pharma's lead compound LP2, a novel lanthipepti...
- Nikon and Lonza Form Collaboration in Japan (2015-05-07)
Lonza, the world’s leading developer and manufacturer of cells for regenerative medicine therapeutics, and Nikon Corporation announced today an exclusive collaboration in the field of cell and gene therapy manufacturing in Japan. Nikon will have access to Lonza’s q...
- Themis Bioscience Raises €7m in First Closing of Series B (2015-05-05)
Themis Bioscience (‘Themis’), a biotechnology company developing innovative prophylactic vaccines for emerging tropical infections, announced today the first closing of EUR 7 Million in a Series B financing of up to EUR 10 Million, led by new investor Wellington Pa...
- MorphoSys Reports Results for First Three Months of 2015 (2015-05-05)
Conference call (in English) today at 2:00pm CEST (1:00pm GMT/8:00am EST) MorphoSys AG (FSE: MOR; Prime Standard Segment; TecDAX, OTC: MPSYY) today announced its financial results for the three months ending 31 March 2015. Group revenues increased to EUR 70.4 ...
- Bayer CropScience and Flagship Ventures Enter Partnership (2015-05-05)
Boosting innovation capacities through venture capital and strategic collaborations Striving to push the bounds of agricultural innovation, Bayer CropScience today announced a strategic innovation partnership with Flagship Ventures, a leading venture capital a...
- Greenovation Files for Phase 1 of moss-aGal in Fabry Disease (2015-05-04)
Today, Greenovation Biotech GmbH filed a phase I clinical trial application (CTA) for its drug candidate moss-alpha-galactosidase (moss-aGal), a moss-made biopharmaceutical compound intended for use as enzyme replacement therapy in patients suffering from Fabry Dis...
- Cambridge Bioscience Distributes Sygnis’ Products in UK & IE (2015-05-04)
> Significant expansion of product roll-out into one of the most important life science markets in Europe > Cambridge Bioscience is a specialized distributor with a strong focus on all areas of life science research > TruePrime™ as well as SunScript™ products...
- Cytena GmbH Raises €1.1m Seed Capital (2015-04-29)
cytena GmbH, headquartered in Freiburg, has developed a device called cy-Clone to separate single cells. A consortium made up of a private investor and High-Tech Gründerfonds (HTGF), will provide EUR 1.1 million of seed capital. cytena GmbH will use this capital in...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to email@example.com and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)